LTR 89: Navigating uncertain times at the FDA

This is a free preview of a paid episode. To hear more, visit naveenagarwalphd.substack.com

Summary

“For the foreseeable future, core FDA practices such a reviewing submissions and post-market oversight are going to continue. Smart Money says FDA in 6 months or an year from now, as to these core responsibilities, is operating similarly to FDA of mid-2024.”

Yes, there is a lot of uncertainty due to the current political environment in the USA, a…